HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

about

Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

P2860

Q56989931-4906B056-00ED-4953-8457-7BC38E6C3FE8 Q57485010-5A80529C-4A43-44D0-ABE3-915C4F14C096

P2860

HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

Item

http://www.wikidata.org/entity/Q38657888

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

HBV Drug Resistance Substituti ...... nalysis by GenBank Data Mining

@en

type

Item

label

HBV Drug Resistance Substituti ...... nalysis by GenBank Data Mining

@en

prefLabel

HBV Drug Resistance Substituti ...... nalysis by GenBank Data Mining

@en

P1476

HBV Drug Resistance Substituti ...... nalysis by GenBank Data Mining

@en

P2093

Hui Zhuang

http://www.w3.org/2001/XMLSchema#string

Kuanhui Xiang

http://www.w3.org/2001/XMLSchema#string

Mingze Su

http://www.w3.org/2001/XMLSchema#string

Wei Ji

http://www.w3.org/2001/XMLSchema#string

Yao Li

http://www.w3.org/2001/XMLSchema#string

Yutang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-HBV Drugs: Progress, Unmet Needs, and New Hope

Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing

rtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus

Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy.

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Antiviral treatment of chronic hepatitis B virus (HBV) infections

P31

scholarly article

P356

10.3390/V9080199

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tong Li

Xizhan Xu

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28749433

http://www.w3.org/2001/XMLSchema#string

P921

bioinformatics

drug approval

P932

5580456

http://www.w3.org/2001/XMLSchema#string

HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

about

P2860

P2860

HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932